Eisai Opens Second Latin America Subsidiary

Eisai, Inc. and its parent company Eisai Co., Ltd. established a subsidiary company in Mexico, Eisai Laboratorios, S. de R.L. de C.V. (Eisai Mexico) based in Mexico City.

The company will establish an initial infrastructure to support operations for entry into the Mexican market. Eisai Mexico’s commercial focus will include neurology, oncology and critical care. Earlier this year, the company established a subsidiary in Latin America, Eisai Brazil.
 
“Eisai is very pleased to continue expansion into Latin America with our newest subsidiary, Eisai Mexico,” said Hajime Shimizu, president, New Markets and ASEAN, Eisai Co., Ltd. “The establishment of this new company enables Eisai to introduce many of its products to people living in Mexico who currently do not have access to these medicines, and this is essential to Eisai’s human health care (hhc) mission to satisfy unmet medical needs and contribute to the health and well-being of people worldwide.”